162, rue du faubourg
75008 Paris - France
Tel. : +33 (0)1 42 60 00 22
Fax : +33 (0)1 42 60 00 63 firstname.lastname@example.org
Management quality commitment
Ad Rem Technology produces and markets medical devices based on electrostimulation with the aim of bringing new effective treatment solutions to patients and health care professionals.
Ad Rem Technology established, continue to manage and maintain a quality management system sustaining its effectiveness in accordance with the requirements of the Quality Management standards ISO 13485:2003 (including for Canada and Taiwan), ISO 9001:2008, US QSR and all other applicable quality standards ...
Ad Rem Technology commits to comply with country’s specific regulations where the products are marketed.
We decided to set up a Quality management system, in order to:
prepare a straightforward organisational framework suited to our organisation enabling us to manage growth
to well define the different functions and responsibilities of each employee within the company
anticipate customer needs and improve the customer satisfaction
expand our international market
satisfy the regulatory requirements, worldwide
Measurable objectives and indicators shall be defined through management review and released. These indicators will enable the progress accomplished, to be measured.
We undertake to carry out this quality policy and to provide all the human and material means necessary for the setting up and continuous improvement of a quality management system.
Because of the importance we attach to this procedure and the size of the company, the Quality Manager appointed for Ad Rem Technology is one of the managing directors.
The success of this approach is guaranteed because of the involvement of all company staff members and I know that we can count on their experience, competence and motivation to achieve the objectives we have set ourselves».
Paris, The18th of March 2011, Managing Directors Thierry Tavidian and Pierre-Michel Amiel
VEINOPLUS® is a medical electro-stimulation device with therapeutic effects upon various symptoms of Venous Insufficiency. These effects have been demonstrated and documented in several clinical studies made since 2004 in France, UK, USA and Russia
Over 100 000 people with venous problems in 25 countries have already chosen the technology VEINOPLUS STRONG>